Physician profile
Ryan Robertson
NPI 1184987117
$133,323.40
in general payments reported to CMS, 2019-2025
9 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,982 · 2020: $12K · 2021: $1,352 · 2022: $29K · 2023: $24K · 2024: $45K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $70K · Travel and Lodging: $9,379 · Food and Beverage: $2,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $69,973.85 |
| Travel and Lodging | $9,378.92 |
| Food and Beverage | $2,779.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $116,531.37 | 2019-2025 | Velys, Attune, Tfn-Advance |
| Depuy Synthes Products, INC. | $13,304.53 | 2019-2024 | Velys |
| Depuy Synthes Sales INC. | $2,235.71 | 2019-2025 | Attune, Velys, Actis |
| Stryker Corporation | $780.97 | 2019-2023 | Mako, Triathlon, Tritanium |
| Zimmer Biomet Holdings, INC. | $279.70 | 2019-2022 | |
| Si-Bone, INC. | $108.14 | 2021 | |
| Arthrex, INC. | $58.73 | 2020 | |
| Medtronic USA, INC. | $12.94 | 2019 | |
| Fortis Surgical, LLC | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.